Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of June 17, 2024
Click Here to Manage Email Alerts
In this edition, screening program identifies airways disease in previously undiagnosed COPD, positive results show benefits of subcutaneous bispecifics and more.
Read the full coverage here:
Lung cancer screening program identifies airways disease in previously undiagnosed COPD
Positive results in lung cancer show benefits of subcutaneous bispecifics
Adagrasib delays progression of pretreated KRAS-mutant lung cancer
Durvalumab extends survival in limited-stage small-cell lung cancer
Osimertinib delays progression ‘way more’ than hoped in EGFR-mutant lung cancer
References:
Bernstein E, et al. JCO Precis Oncol. 2024;doi:10.1200/po.23.00447.
Leighl NB, et al. Abstract LBA8505. Presented at: ASCO Annual Meeting; May 30–June 3, 2024; Chicago.
Ramalingam SS, et al. Abstract LBA4. Presented at: ASCO Annual Meeting; May 31-June 4, 2024: Chicago.
Seigo MA, et al. Pulmonary comorbidities, respiratory symptoms, and spirometry in a real-world, urban lung cancer screening program. Presented at: American Thoracic Society International Conference; May 17-22, 2024; San Diego.
Spigel DR, et al. Abstract LBA3. Presented at: ASCO Annual Meeting; May 31-June 4, 2024: Chicago.
Collapse
Read more about
Click Here to Manage Email Alerts
